![Jason D. Menzo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason D. Menzo
Chief Executive Officer at
The Foundation Fighting Blindness, Inc.
Profile
Jason D.
Menzo is the founder of Opus Genetics, Inc., a company founded in 2021.
He is currently the Chief Executive Officer at The Foundation Fighting Blindness, Inc., a position he has held since 2022.
Jason D. Menzo active positions
| Companies | Position | Start |
|---|---|---|
The Foundation Fighting Blindness, Inc.
 The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services Provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome | Chief Executive Officer | 01/07/2022 |
Former positions of Jason D. Menzo
| Companies | Position | End |
|---|---|---|
Opus Genetics, Inc.
 Opus Genetics, Inc. BiotechnologyHealth Technology Provides clinical stage gene therapies for inherited retinal diseases | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
87
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services Provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome | Commercial Services |
Opus Genetics, Inc.
Opus Genetics, Inc. BiotechnologyHealth Technology Provides clinical stage gene therapies for inherited retinal diseases | Health Technology |
- Stock Market
- Insiders
- Jason D. Menzo
